R I Fisher

A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study

R I Fisher, Steve Dahlberg, BN Nathwani et al. · Blood · 1995 · 347 citations · Full text

Medicine, Hematology, Oncology +17

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.

Bruce W. Dana, Steve Dahlberg, Bharat N. Nathwani et al. · Journal of Clinical Oncology · 1993 · 193 citations

Medicine, Oncology, Chemotherapy +13

Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma

R I Fisher, SM Hubbard, V T DeVita et al. · Blood · 1981 · 162 citations · Full text

Veterinary Medicine, Oncology, Pathology +14

Lymphoma classification--the gap between biology and clinical management is closing

Wolfgang Hiddemann, DL Longo, Bertrand Coiffier et al. · Blood · 1996 · 132 citations · Full text

Medicine, Cancer Biology, Oncology +14

Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy.

Dan L. Longo, Eli Glatstein, P L Duffey et al. · Journal of Clinical Oncology · 1989 · 122 citations

Medicine, Hematology, Oncology +17